A third COVID-19 vaccine, this one from AstraZeneca, reported Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90% effective in preventing disease.
The results are based on...
Pfizer Inc. and its German partner, BioNTech SE will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable...
In a press release issued today, Pfizer said that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying — the last data needed to...
Updated data from researchers at John Hopkins University showed 143,200 cases were added on Wednesday, topping the record set the day before by almost 3,000 cases. Wednesday was the fifth single-day case record in nine days.
In a note to clients Tuesday, SVB Leerink analyst Geoffrey Porges said
the recent results from Pfizer's early COVID-19 vaccine data should “boost
confidence of the general public in COVID vaccines, which should drive up the
early adoption rate.” The analysts see Pfizer’s...
President-elect Joe Biden hit the ground running Monday morning with an announcement of his transition team’s COVID-19 advisory board. The advisory board will be co-chaired by public health experts including Rick Bright, a vaccine expert and the former...
Pfizer and its partner BioNTech, has released promising interim data from the Phase III COVID-19 vaccine trial. The data suggest a 90% efficacy rate for the vaccine.
Initially, the plan was to conduct...
Yesterday, the US set an alarming record for the number of new coronavirus cases in a single day, recording more than 100,000 cases of the deadly virus.
According to a NYT tally, the US...
Major drugmaker, AstraZeneca said they will have results from crucial studies of its COVID-19 vaccine by the end of the year, the company said Thursday.
AstraZeneca’s COVID-19 shot is one of four in the...
Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, warned that the United States is primed to experience "a whole lot of hurt" as winter approaches due to the potential for surging coronavirus cases...
Pfizer has announced the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptide (CGRP)...
